Sailian yoghurt-source plant lactobacillus R2-5 and application of Sailian yoghurt-source plant lactobacillus R2-5

By adjusting the intestinal flora by the R2-5 plant-based Lactobacillus isolated from Sailimu yogurt, the problems of health risks related to hyperlipidemia and obesity were solved, and safe and effective lipid-lowering and weight loss effects were achieved, avoiding traditional Side effects of the drug.

CN119081957APending Publication Date: 2024-12-06HEBEI AGRICULTURAL UNIV.
View PDF 10 Cites 0 Cited by

Patent Information

Application Number
CN202411348959.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-26
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The prior art is difficult to effectively and safely reduce the health risks associated with hyperlipidemia and obesity. Traditional drugs often bring serious side effects, so we will seek a safe, effective and green and healthy treatment.

Method used

Lactobacillus plantarum R2-5 was isolated from sialimum yogurt, by regulating intestinal flora and reducing cholesterol and lipid accumulation, using compositions or food additives prepared by this strain as microbial preparations or pharmaceutical compositions, in the prevention and treatment of hyperlipidemia.

Benefits of technology

Significantly reduce the serum TC, TG and LDL-C levels of mice, increase HDL-C, reduce liver and abdominal fat accumulation, improve intestinal microbiota, enhance short-chain fatty acid production, inhibit obesity-related bacterial groups, and reduce lipid accumulation. Provides safe and effective lipid-lowering and weight loss effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119081957A_ABST
    Figure CN119081957A_ABST
Patent Text Reader

Abstract

The invention discloses a Sailian yoghurt source plant lactobacillus R2-5 and an application of the Sailian yoghurt source plant lactobacillus R2-5. The bacterium is separated from Sailiu yoghourt in Aksu region of Xinjiang, and has good in-vivo and in-vitro lipid lowering capacity. High-fat diet is adopted to induce obesity of mice, the mice are treated by the aid of the plant lactobacillus R2-5 in an intragastric administration manner, body weight and lipid abnormality of treated groups can be obviously improved, and accumulation of fat in livers and abdomens can be obviously reduced. The diversity analysis of intestinal microorganisms shows that R2-5 intervenes and changes the composition of intestinal microbiota, increases the abundance of short-chain fatty acid producing bacteria and potential beneficial bacteria, and inhibits the flora related to obesity at the same time, thereby changing the metabolic activity of the intestinal tract. Key metabolic pathways and metabolites are excavated through a multi-omics technology, and the lipid-lowering mechanism is that N6, N6-dimethyl-L-lysine is remarkably increased, the generation of carnitine in the liver is promoted, and the beta-oxidation of long-chain fatty acid is enhanced, so that the accumulation of early lipid is effectively reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of microorganisms, and in particular relates to a Sayram yogurt-derived Lactobacillus plantarum R2-5 and an application thereof. Background Art

[0002] As of 2024, the prevalence of obesity continues to rise worldwide, posing a major challenge to global public health. The latest estimates show that more than one billion people are affected by obesity worldwide, including approximately 880 million adults and 159 million children and adolescents. Addressing this global health challenge is critical because obesity increases the risk of associated comorbidities, such as type 2 diabetes, coronary heart disease, and hypertension. Obesity is also closely related to life expectancy, especially central obesity, and severe obesity is significantly associated with an increased risk of premature death. Obesity is closely associated with risk factors for cardiovascular disease, especially dyslipidemia. Managing blood lipid levels is essential to prevent obesity and its complications. The methods for reducing high blood lipids are generally diet control, physical exercise, and smoking cessation. However, in severe cases, drug treatment is required, such as statins, phenoxy aromatic acids, niacin, and bile acid chelators, but these drugs usually have serious side effects, such as nausea, abdominal pain, allergic reactions, hair loss, and muscle degeneration. Therefore, finding a safe, effective, green and healthy new treatment method is an urgent task at present. Microbial preparations have gradually entered the public eye and are gradually gaining public recognition due to their safety and availability.

[0003] Lactic acid bacteria are a group of bacteria that can ferment carbohydrates and produce lactic acid. They are widely found in nature, fermented foods, and the human gastrointestinal tract, providing a variety of health benefits. Lactic acid bacteria have many characteristics, including the ability to produce lactic acid and inhibit the growth of pathogenic bacteria, acid and bile salt resistance, and strong adhesion ability. Lactic acid bacteria provide many probiotic functions, including (1) improving the composition of intestinal microbiota, (2) enhancing immune function, and (3) treating depression. Developing new functions for lactic acid bacteria is a focus of research in this field. Summary of the invention

[0004] The purpose of the present invention is to provide a Sayram yogurt-derived Lactobacillus plantarum R2-5 and application thereof.

[0005] The invention separates a series of lactic acid strains from Sayram yogurt, performs preliminary identification by sequencing 16S rDNA thereof, uses strains R6-3 and R4-2 from the same source as control strains, and evaluates the cholesterol-lowering ability of the strains through in vitro tests; further, through in vivo tests, high-fat diet-induced hyperlipidemia mice are used as animal models to test whether the screened plant lactobacillus R2-5 with weight loss and lipid-lowering effects has a probiotic effect on hyperlipidemia mice by regulating intestinal flora for prevention and treatment.

[0006] A Sayram yogurt-derived Lactobacillus plantarum R2-5, whose preservation number is CGMCC NO.31107.

[0007] The use of the Sayram yogurt-derived Lactobacillus plantarum R2-5 in preparing a composition capable of preventing lipid accumulation by regulating intestinal flora.

[0008] A composition comprises the Sayram yogurt-derived Lactobacillus plantarum R2-5.

[0009] A food comprises the Sayram yogurt-derived Lactobacillus plantarum R2-5.

[0010] A food additive comprises the Sayram yogurt-derived Lactobacillus plantarum R2-5.

[0011] A microbial preparation comprises the Sayram yogurt-derived Lactobacillus plantarum R2-5.

[0012] A pharmaceutical composition comprises the Sayram yogurt-derived Lactobacillus plantarum R2-5.

[0013] The Sailimu yogurt source plant lactobacillus (Lactiplantibacillus plantarum) R2-5 of the present invention is classified and named as plant lactobacillus Lactiplantibacillus plantarum, with a preservation date of June 27, 2024 and a preservation number of CGMCC NO. 31107. The name of the preservation unit is the General Microbiological Center of the China Microbiological Culture Collection Administration, and the address is No. 3, No. 1 Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences, Postal Code 100101.

[0014] Beneficial effects of the present invention: The in vitro prebiotic function test of the Sayram yogurt-derived plant lactobacillus R2-5 disclosed in the present invention shows that the R2-5 bacteria / fermentation supernatant have a strong cholesterol-lowering ability. The R2-5 bacteria were proved by the animal model of hyperlipidemia induced by a high-fat diet in mice. The treatment group showed significant improvements in body weight and lipid abnormalities, and the accumulation of liver and abdominal fat was significantly reduced, such as: serum TC decreased by 25.7%, TG decreased by 45%, LDL-C decreased by 30%, and HDL-C doubled. Analysis of intestinal microbial diversity showed that R2-5 intervention changed the intestinal microbiota, increased the abundance of short-chain fatty acid (SCFA)-producing bacteria (such as Lactobacillus, Roseburia) and potential beneficial bacteria (such as Turicibacter and Christensenella), and inhibited the bacteria associated with obesity (such as Alistipes and Bilophila), thereby changing the metabolic activity of the intestine. Through multi-omics technology, key metabolic pathways and metabolites were identified. The lipid-lowering mechanism involves a significant increase in N6,N6-dimethyl-L-lysine (a precursor for carnitine synthesis), which promotes the production of carnitine in the liver and enhances the β-oxidation of long-chain fatty acids, thereby effectively reducing the accumulation of early lipids. BRIEF DESCRIPTION OF THE DRAWINGS

[0015] Figure 1 The figure shows the in vitro cholesterol-lowering index levels of the strains. The superscript lowercase letters in the figure represent significant differences at the P<0.05 level, and the superscript uppercase letters represent significant differences at the p<0.01 level.

[0016] Figure 2 It is a line graph of the body weight of mice in different treatment groups. *P<0.05 and **P<0.01 indicate the significant difference between the two groups.

[0017] Figure 3 It is a horizontal chart of the organ index of mice in different treatment groups. Lowercase letters ac represent P<0.05. The same letters between groups indicate no difference between the groups, and different letters indicate significant difference between the groups.

[0018] Figure 4 H&E staining images of liver tissues of mice in different treatment groups, the scale bar indicates 200μm, and the microscope magnification is 400 times.

[0019] Figure 5 Oil red o staining of the liver of mice in different treatment groups, the scale bar indicates 200 μm, and the microscope magnification is 400 times.

[0020] Figure 6 H&E staining images of inguinal adipose tissue of mice in different treatment groups, the scale bar indicates 200μm, and the microscope magnification is 400 times.

[0021] Figure 7 Inguinal fat index and adipocyte size in different treatment groups, where A~C represent inguinal fat index, average size of inguinal adipocytes, and frequency of adipocyte area, respectively.

[0022] Figure 8 Figure 2 shows the levels of serum lipid content and related enzyme physicochemical indexes in different treatment groups. Lowercase letters ac represent P < 0.05. The same letters between groups indicate no difference between the groups, and different letters indicate significant difference between the groups.

[0023] Fig. 9 This is a graph of the index levels of liver damage in mice under different treatment groups. Lowercase letters ac represent P<0.05. The same letters between groups indicate no difference between the groups, and different letters indicate significant differences between the groups.

[0024] Fig.10 The expression diagrams of lipid metabolism-related genes in liver and adipose tissue of different treatment groups, among which the superscript lowercase letters (ac) represent significant differences at the P=0.05 level when comparing different treatment groups.

[0025] Fig.11 The principal coordinate analysis (PCoA) method was used to analyze the β diversity of intestinal flora of mice in different treatment groups at the OTU level.

[0026] Fig.12 The Chao index and Shannon index were used to analyze the α diversity of intestinal flora in mice in different treatment groups. Compared with the HFD group, ** was significant at the 0.01 level, and *** was significant at the 0.001 level.

[0027] Fig.13 Species composition and difference analysis level diagram of each sample phylum level in different treatment groups.

[0028] Fig.14 Species composition and difference analysis level diagram of each sample at the genus level for different treatment groups.

[0029] Fig.15 This is a horizontal chart for analyzing the changes in abundance of beneficial bacteria related to obesity in different treatment groups. Lowercase letters ac represent P<0.05. The same letters between groups indicate no difference between groups, and different letters indicate significant differences between groups.

[0030] Fig.16 The figures are the analysis levels of species or strains that may be potentially harmful at the genus level related to obesity in different treatment groups. Lowercase letters ac represent P<0.05. The same letters between groups indicate no difference between groups, and different letters indicate significant difference between groups.

[0031] Fig.17This is a horizontal network analysis diagram of the correlation between genera in different treatment groups. The red line in the figure indicates positive correlation, the blue line indicates negative correlation, the line thickness represents the correlation strength, and the node size is determined by the abundance of the bacteria or pathway. The Arabic numerals in the figure represent 1: ASF356; 2: Peptococcaceae (*Unclassified); 3: Akkermansia; 4: Desulfovibrio; 5: Desulfovibrionaceae (*Unclassified); 6: Muribaculaceae (*Unclassified); 7: Rikenellaceae (*RC9 gut group); 8: Lachnospiraceae (*UCG-006); 9: UCG-009, 10: Eubacterium brachy group; 11: Oscillospiraceae (*Unclassified); 12: Christensenellaceae (*Unclassified); 13: Parabacteroides; 14: Alistipes; 15: Lachnospiraceae (*NK4A136 group); 16: Ruminococcaceae (*Unclassified); 17: Acetivibrio ethanolgignens group; 18: Lachnospiraceae (*Unclassified); 19: Bacteroides; 20: Lachnospiraceae (*FCS020group); 21: Harryflintia; 22: Psychrobacter; 23: Prevotellaceae (*Unclassified); 24: Enteractinococcus; 25: Eubacterium xylanophilum group; 26: Bacillaceae (*Unclassified); 27: Sporosarcina; 28: Pseudogracilibacillus; 29: Oceanisphaera; 30: Oscillibacter; 31: Roseburia; 32: Lachnoclostridium; 33: Colidextribacter; 34: Blautia; 35: Clostridium sensustricto1;36:Atopostipes;37:Facklamia;38:Lacticigenium;39:Gastranaerophilales(**Unclassified); 40:Clostridia(**vadinBB60 group); 41: Turicibacter; 42: Erysipelatoclostridiaceae (*Unclassified); 43: RF39 (**Unclassified); 44: Defluviitaleaceae (*UCG-011); 45: Odoribacter; 46: Anaeroplasma; 47: Christensenellace ae(*R-7group); 48: Romboutsia; 49: Clostridia (***Unclassified); 50: Prevotellaceae (*Ga6A1group); 51: Rhodospirillales (**Unclassified); 52: Anaerovoracaceae (*Unclassified); 53: Candidatus Saccharimonas; 54: Bifidobacterium; 55: Peptococcus; 56: Coriobacteriaceae (*UCG-002); 57: Muribaculum; 58: Clostridia (**UCG-014); 59: Family XIII UCG-001; 60: UBA1819; 61: Eubacterium fissicatena group.;

[0032] Fig.18 The figure shows the levels of short-chain fatty acids in mouse feces in different treatment groups. Lowercase letters ac represent P<0.05. The same letters between groups indicate no difference between the groups, and different letters indicate significant difference between the groups.

[0033] Fig.19 This is a network diagram of the correlation between the short-chain fatty acid content in feces and intestinal flora for different treatment groups. The red line in the figure indicates positive correlation, the blue line indicates negative correlation, the line thickness represents the strength of correlation, and the node size is determined by the abundance of bacteria or pathways.

[0034] Fig. 20 Correlation network between fecal short-chain fatty acid content and pathways for different treatment groups Network relationship between intestinal microbiota, the size of the node is determined by the abundance of bacteria or metabolic pathways. Red represents positive correlation and green represents negative correlation.

[0035] Fig.21Metabolic pathways and metabolite analysis diagrams for different treatment groups. (A) Relationship between lysine biosynthesis, methionine biosynthesis, fatty acid synthesis and carnitine synthesis. (BG) KEGG homology (KO) difference significance analysis. (H) Intestinal metabolite N6, N6-dimethyl-L-lysine difference significance analysis. (I) Glycerol degradation pathway. (JK) KEGG homology (KO) difference significance analysis. KEGG genes in red indicate upregulation, while green indicates downregulation. Data are expressed as mean ± standard deviation (n = 6). Different letters indicate significant differences between groups (P < 0.05). Lowercase letters ac represent P < 0.05. The same letters between groups indicate no difference between groups, and different letters indicate significant differences between groups; ***P < 0.001 indicates extremely significant differences between groups in pairwise comparisons.

[0036] Fig. 22 The lipid-lowering mechanism of Lactobacillus plantarum R2-5. In the figure, red KEGG genes indicate upregulation, while green indicates downregulation. DETAILED DESCRIPTION

[0037] In order to facilitate the understanding of the present invention, the present invention will be described more fully below. However, the present invention can be implemented in many different forms and is not limited to the embodiments described herein. On the contrary, the purpose of providing these embodiments is to make the understanding of the disclosure of the present invention more thorough and comprehensive.

[0038] Example 1 In vitro cholesterol-lowering ability determination of R2-5

[0039] Using LGG as the control strain, the cholesterol-lowering ability of 8 suspected Lactobacillus plantarum strains was determined. The ability of the strain to degrade cholesterol was determined as follows: 0, 0.1, 0.2, 0.3, 0.4, and 0.5 mL of a cholesterol solution with a mass concentration of 1 mg / mL was added to a 10 mL test tube, and then 1, 0.9, 0.8, 0.7, 0.6, and 0.5 mL of anhydrous ethanol were added in sequence, and then 2 mL of ammonium ferric sulfate reagent was slowly added in sequence, mixed, and after cooling to room temperature, the absorbance was measured at a wavelength of 560 nm. A standard curve was prepared with cholesterol concentration as the horizontal axis and absorbance as the vertical axis. The strain activated to the end of the logarithmic phase was inoculated into the cholesterol MRS medium at a volume ratio of 1%, and cultured at 37°C until the stable phase. The culture solution was centrifuged at 5000 r / min for 10 min, 2 mL of the supernatant was taken into a clean test tube, 8 mL of anhydrous ethanol was added, and the mixture was shaken. The culture solution was centrifuged at 4500 r / min for 10 min, 1 mL of the supernatant was taken into a new clean test tube, 2 mL of ammonium ferric sulfate colorimetric solution was added, and the mixture was shaken. After cooling, the absorbance value was measured at 560 nm, which was the A sample. The cholesterol MRS medium without the strain inoculation was used as the control, which was the A control. The cholesterol reduction rate was calculated according to formula (1).

[0040]

[0041] The results are as follows Figure 1 As shown, the ability of R2-5, R2-7 and R4-2 to degrade cholesterol was significantly higher than that of the control strain LGG (P<0.01), the ability of R6-1 to degrade cholesterol was significantly higher than that of the control strain LGG (P<0.05), the ability of R6-2 to degrade cholesterol was not significantly different from that of LGG (P>0.05), and the ability of R2-8, R5-1 and R6-3 to degrade cholesterol was significantly lower than that of the control strain LGG (P<0.01).

[0042] Example 2 Lactobacillus plantarum R2-5 inhibits lipid accumulation in mice induced by high-fat diet by regulating intestinal flora

[0043] 1. Animal experiment design

[0044] Sixty male specific pathogen-free (SPF) C57BL / 6J mice aged 6 weeks were selected and provided by Beijing Huafukang Biotechnology Co., Ltd. (Beijing, China) and maintained in a constant environment (12 h light-12 h dark cycle, (22°C ± 1)°C). All animal procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals of Hebei Agricultural University and were reviewed and approved by the Laboratory Animal Ethics Committee of Hebei Agricultural University. Five experimental groups (12 mice in each group) were established: (1) normal control group (NC) (2) high-fat diet group (HFD) (3) HFD+R6-3, high-fat diet + Lactobacillus plantarum R6-3 strain. (4) HFD+R4-2, high-fat diet + Lactobacillus plantarum R4-2 strain (5) HFD+R2-5, high-fat diet + Lactobacillus plantarum R2-5 strain. The NC group was fed with TP28622 feed. The other groups were fed with TP28620 high-fat diet to establish a high-fat mouse model. The feed ingredients are shown below and were provided by Nantong Trofi Feed Technology Co., Ltd. (Jiangsu, China). Mice in the HFD+R6-3, HFD+R4-2, and HFD+R2-5 groups were orally gavaged with 0.2 mL of 5×10 9 (CFU) / mL of strain suspensions of R6-3, R4-2, and R2-5 for 12 weeks. The NC group and the HFD group were gavaged with an equal amount of normal saline every day. Before the start of the experiment, all mice had similar body weights and had free access to food and water during the experiment. Throughout the experiment, water, bedding, and high-fat diet were changed regularly every week. The body weight of each mouse was recorded every week.

[0045] After 12 weeks of feeding, feces were collected and stored at -80°C. The mice were fasted for 12 hours, weighed, blood was collected from the eyeballs, and then killed by cervical dislocation. Serum and tissues (heart, liver, spleen, kidney, inguinal fat) were collected for analysis. A portion of fresh liver and inguinal fat was immediately fixed with 4% buffered formalin at room temperature, and then the liver was stained with hematoxylin and eosin (H&E) and oil red o, and the adipose tissue was stained with hematoxylin and eosin (H&E). The remaining organs and adipose tissue were quickly frozen with liquid nitrogen and stored at -80°C for further analysis. This animal experiment method was reviewed and approved by the Experimental Animal Ethics Committee of Hebei Agricultural University (2024138).

[0046]

[0047] 2. Effects on mouse body weight and organ indexes

[0048] Changes in body weight and organ indexes of mice in different treatment groups during the 12-week experimental period Figure 2 and Figure 3 As shown. Figure 2 In the experiment, after 12 weeks, the weight of the mice in the five groups increased steadily. With the intervention of the strain, the weight gain of the mice was inhibited, and the weight of the mice in each group began to differ in the fifth week (P<0.05). The weight of the mice in the HFD group was the heaviest until the 12th week, and then the weight of the mice in the HFD-R6-3 group, HFD-R4-2 group, and HFD-R2-5 group decreased in turn. In the 12th week, there was a very significant difference in weight between the HFD group and the HFD-R2-5 group (P<0.01). It can be observed that the intervention of Lactobacillus plantarum R2-5 can significantly inhibit the weight gain of mice caused by a high-fat diet.

[0049] exist Figure 3 As shown in the figure, the organ index of mice can reflect the growth status of mice. Long-term high-fat diet will cause fat accumulation in the internal organs of mice, thereby increasing their mass. Compared with the NC group, the organ index of mice in the HFD group increased significantly, including liver (P<0.05), heart (P<0.05), spleen (P<0.05), and kidney (P<0.05). However, after intervention with Lactobacillus plantarum R2-5, the organ index was significantly reduced compared with HFD, including liver (P<0.05), heart (P<0.05), spleen (P<0.05), and kidney (P<0.05). The effect of Lactobacillus plantarum R2-5 strain was better than that of Lactobacillus plantarum R4-2 strain, and Lactobacillus plantarum R4-2 strain was better than that of Lactobacillus plantarum R6-3 strain.

[0050] 3. H&E staining of liver and adipose tissue and Oil Red O staining of liver tissue

[0051] The liver and inguinal adipose tissue were washed with phosphate buffered saline and then immersed in 10% formalin solution for 24 hours, embedded in paraffin, cut into tissue slices with a thickness of 5 μm, and finally stained with hematoxylin and eosin (H&E). The liver slices were stained with oil red o, and the frozen liver slices were cut into 8 μm thickness and stained with oil red o aqueous solution (0.5% Oil Red O stocksolution:H2O,6:4,v / v) for 30 minutes. After that, the liver slices were counterstained with hematoxylin, and then the slices were placed in glycerol and photographed under an optical microscope. This operation process was completed at Wuhan Seville Biotechnology Co., Ltd.

[0052] like Figure 4 As shown in the figure, H&E staining of the liver showed no vacuolation in the liver of mice in the NC group. The structure of hepatocytes is relatively complete, neatly arranged, and the nuclei are orderly located in the center of the cells. However, severe vacuolation was observed in the cytoplasm of liver tissue of mice fed with HFD, lipid deposition increased, irregular arrangement of hepatocytes, marginalization of nuclei, and fat foaming. After intervention with Lactobacillus plantarum R2-5, the degree of lipid deposition and vacuolation in the cytoplasm of liver tissue cells was reduced, and the absorption of fat in the body was prevented, and the difference with the NC group was significantly reduced. As can be seen from the figure, Lactobacillus plantarum R4-2 and R6-3 can also reduce lipid deposition. Lactobacillus plantarum R4-2 is better than R6-3, but the effect is not as significant as Lactobacillus plantarum R2-5.

[0053] like Figure 5 Oil red o staining of mouse liver showed that the red lipid droplets in the liver of mice in the HFD group were significantly higher than those in the NC group. After intervention with Lactobacillus plantarum R2-5, the lipid droplets in the liver were significantly reduced, making the liver morphology closer to that of the NC group. Lactobacillus plantarum R4-2 and R6-3 also showed some improvement, but the effect was not as significant as that of Lactobacillus plantarum R2-5.

[0054] Figure 6 In the study, compared with the NC group, the adipocytes in the HFD group induced by high-fat diet became larger, had blurred structures, and had obvious lesions in the adipocytes. After intervention with Lactobacillus plantarum R2-5, this phenomenon was significantly improved, making the morphology of inguinal white adipose tissue closer to the NC group with a normal diet, with small adipocytes, compact arrangement, and no lesions. Lactobacillus plantarum R6-3 and R4-2 can also reduce adipocyte degeneration, but the effect is not as significant as that of Lactobacillus plantarum R2-5.

[0055] Figure 7As shown in (A), the fat index of the HFD group increased significantly compared with the NC group (P<0.05). Compared with the HFD group, Lactobacillus plantarum R2-5 significantly reduced the fat index after 12 weeks of intervention (P<0.05). Lactobacillus plantarum R4-2 also significantly reduced the fat index compared with the HFD group (P<0.05), while there was no significant difference between Lactobacillus plantarum R6-3 and the HFD group. Figure 7 As shown in (B), compared with the NC group, the size of adipocytes in the HFD group increased significantly (P<0.01), and after intervention with Lactobacillus plantarum R2-5, the size of adipocytes was significantly reduced (P<0.01). Lactobacillus plantarum R4-2 also significantly reduced the size of adipocytes (P<0.05), but the effect was not as good as that of Lactobacillus plantarum R2-5. There was no significant difference between Lactobacillus plantarum R6-3 and the HFD group. In summary, R2-5 can significantly reduce the enlargement of white adipocytes and the blurring of their structure. Figure 7 As shown in (C), from the distribution of adipocyte size, the area of ​​cells in the NC group was mainly concentrated in the range of less than 5000 μm. 2 、5000~11000μm 2 However, the adipocyte area of ​​the HFD group was mainly distributed in the range of 23000 to 25000 μm 2 and greater than 25000μm 2 ; Lactobacillus plantarum R2-5 significantly inhibited the enlargement of adipocytes after intervention, and the cell size was mainly distributed in the range of 5000-9000 μm 2 ; Lactobacillus plantarum R4-2 can also inhibit the enlargement of adipocytes, but the effect is not as good as that of Lactobacillus plantarum R2-5. Its cell size is mainly distributed in the range of 9000 to 17000 μm 2 The cell size of Lactobacillus plantarum R6-3 is mainly distributed in the range of 17000 to 21000 μm. 2 , but the effect is not as good as the first two strains. This result shows that Lactobacillus plantarum R2-5 can effectively inhibit fat accumulation and reduce fat cell degeneration.

[0056] 4. Blood lipid content and related enzyme indicators

[0057] The levels of TC, TG, HDL-C, LDL-C, and TGH in mouse serum were determined according to the instructions: direct determination. All were determined using kits from Jiancheng Bioengineering Institute (Nanjing, China).

[0058] The results are as follows Figure 8As shown in the results, compared with the NC group, the levels of TC, TG and LDL-C in the serum of mice fed with HFD were significantly increased (P<0.05). HDL-C and TGH were significantly decreased (P<0.05). After 12 weeks of intervention with Lactobacillus plantarum R2-5, the increase of blood lipid levels in mice was effectively inhibited, that is, compared with the HFD group, the R2-5 group significantly decreased TC (P<0.01), TG (P<0.01), LDL-C (P<0.05), and TC in the liver (P<0.05), and significantly increased HDL-C (P<0.05) and TGH (P<0.01). Compared with the HFD group, there was no significant difference in serum TC and HDL-C in the Lactobacillus plantarum R6-3 group (P>0.05), but there were significant differences in serum TG, LDL-C and TGH (P<0.05). Compared with the HFD group, there was no significant difference in serum HDL-C between Lactobacillus plantarum R4-2 (P>0.05), but there were significant differences in TC, TG, LDL-C and TGH (P<0.05). From the above, it can be seen that Lactobacillus plantarum R2-5 is better than Lactobacillus plantarum R4-2 and Lactobacillus plantarum R6-3 in inhibiting the increase of blood lipid levels.

[0059] 5. Serum ALT, AST and TC content in liver

[0060] The levels of ALT and AST in mouse serum and TC in liver were determined according to the instructions: direct determination. All were determined using kits from Jiancheng Bioengineering Institute (Nanjing, China).

[0061] The aim of this study was to investigate the effects of Lactobacillus plantarum R2-5 on cholesterol (TC) in the liver, and ALT and AST in the serum of mice induced by a high-fat diet. ALT and AST are important amino acid transferases in the body and are used as indicators for evaluating liver cell damage. Fig. 9 As shown in the results, compared with the NC group, the ALT and AST levels in the serum of mice fed with HFD were significantly increased (P<0.05). The TC in the liver was also significantly increased (P<0.05). After 12 weeks of intervention with Lactobacillus plantarum R2-5, the elevated ALT and AST levels and liver damage in mice were effectively inhibited, namely, compared with the HFD group, the R2-5 group significantly reduced ALT (P<0.01), AST (P<0.01), and TC in the liver (P<0.05); compared with the HFD group, the Lactobacillus plantarum R6-3 group had no significant difference in TC content in the liver (P>0.05), and there were significant differences in ALT and AST (P<0.05), but the ALT effect was not as significant as that of Lactobacillus plantarum R4-2 and Lactobacillus plantarum R2-5; compared with the HFD group, Lactobacillus plantarum R4-2 significantly reduced ALT (P<0.01), AST (P<0.01), and TC in the liver (P<0.05).

[0062] 6. Determination of genes closely related to lipid metabolism using RT-qPCR

[0063] Total RNA from liver and inguinal adipose tissue was extracted using TriQuick Reagent (Solarbio Life Sciences, China), and cDNA was obtained using EasyScript one-step gDNA removal and cDNA synthesis mixture, using a reverse transcription kit (TransGen Biotech, Beijing, China). Gene expression was determined using Roche Light Cycler 96 (Roche, Switzerland) and analyzed using the company's software system Light Cycler 96SW 1.1. The experiment was repeated three times, and the data analysis used the 2-ΔΔCT method. In order to standardize the data, Gapdh was used as an internal reference gene. RT-qPCR primers were designed, and the specific primer information is shown in Table 1 below.

[0064] Table 1 Primer sequence information

[0065]

[0066] The expression levels of AMPK and AMPK-mediated downstream signals in the liver and adipose tissue were detected to further explore the mechanism by which Lactobacillus plantarum R2-5 inhibited lipid accumulation in HFD-fed mice. With the differentiation of adipocytes and the accumulation of adipose tissue, the levels of SREBP-1c, LPL, and SCD1 will increase. SIRT1, ATGL, HSL, CPT-1, PPARα, and PGC-1α are key factors that promote fat oxidation and decomposition. The upregulation of UCP-1 and UCP-3 increased thermogenesis and energy expenditure.

[0067] Fig.10As shown in (A), the expression levels of fatty acid synthesis and uptake genes LPL, SREBP-1c, and SCD1 in liver tissue of HFD group were significantly upregulated compared with NC group; the expression levels of lipolysis and oxidation genes PPARα, HSL, ATGL, AMPKα, and PGC-1α were significantly downregulated. After intervention with Lactobacillus plantarum R2-5, the fatty acid synthesis and uptake genes LPL (P<0.001), SREBP-1c (P<0.01), and SCD1 (P<0.05) were significantly downregulated. The lipolysis and oxidation genes PPARα (P<0.001), HSL (P<0.05), ATGL (P<0.01), AMPKα (P<0.05), and PGC-1α (P<0.05) were significantly upregulated. However, there was no significant difference in ATGL (P>0.05) and HSL (P>0.05) between Lactobacillus plantarum R4-2 group and HFD group. The remaining genes were significantly different (P<0.05). Compared with the HFD group, the expression levels of LPL (P<0.05), SCD1 (P<0.05), and CPT-1α (P<0.05) in the Lactobacillus plantarum R6-3 group were significantly downregulated, and the expression levels of these three genes were significantly different. The remaining genes were not significantly different (P>0.05).

[0068] like Fig.10As shown in (B), the expression levels of PPARα, UCP-1, CPT-1α, PGC-1α, UCP-3, HSL, ATGL, and AMPKα genes in adipose tissue of the HFD group were significantly downregulated compared with the NC group. After intervention with Lactobacillus plantarum R2-5, the expression levels of PPARα (P<0.01), UCP-1 (P<0.05), CPT-1α (P<0.01), PGC-1α (P<0.05), UCP-3 (P<0.01), HSL (P<0.01), ATGL (P<0.05), and AMPKα (P<0.01) genes were significantly upregulated. However, there were no significant differences in UCP-3 (P>0.05), PPARα (P>0.05), and CPT-1α (P>0.05) between the Lactobacillus plantarum R4-2 group and the HFD group. The remaining genes were significantly different (P<0.05). Compared with the HFD group, only UCP-1 (P<0.05) was significantly upregulated in the Lactobacillus plantarum R6-3 group, and the other genes were not significantly different (P>0.05). Among the lipid metabolism genes in adipose tissue, the effects of the three strains of bacteria on LPL (P>0.05), SREBP-1c (P>0.05), and SCD1 (P>0.05) were not significantly different. Lactobacillus plantarum R2-5, R4-2, and R6-3 were all able to reverse the abnormal expression of the above lipid metabolism genes induced by the HFD diet. Overall, Lactobacillus plantarum R2-5 had a stronger regulatory ability to inhibit the expression of lipid metabolism-related genes than Lactobacillus plantarum R4-2, and Lactobacillus plantarum R6-3 had the weakest effect overall.

[0069] 7. Effects of Lactobacillus plantarum R2-5 on intestinal flora of mice induced by high-fat diet

[0070] Fecal samples of each mouse were collected under sterile conditions 12 h before the end of the experiment, transferred into centrifuge tubes, and stored at -80 °C after being snap-frozen in liquid nitrogen. The samples were sent to Shanghai Meiji Biotechnology Co., Ltd. for experiments, and sequencing experiments and other work were completed at Shanghai Meiji Biotechnology Co., Ltd. High-throughput sequencing was performed using the Illumina MiSeq (Illumina, Shanghai, China) PE300 platform. LEfSe analysis (Linear discriminant analysis Effect Size) (LDA>3, NC-HFD, P<0.05; HFD-R2-5, P<0.01) was used to determine the bacterial groups with significant differences in abundance from the phylum to the genus level between different groups. Distance-based redundancy analysis (db-RDA) was used to investigate the influence of intestinal bacterial community structure. Based on spearman correlation r and significance P, the Cytoscape NetworkAnalyzer plug-in was used to perform correlation network analysis between microbiota and SCFAs, KEGG pathway (ko) and SCFAs, and microbiota and microbiota.

[0071] like Fig.11 As shown in the figure, the distribution of intestinal flora of mice in five different treatment groups was statistically analyzed, and the diversity at the OTU level was analyzed. The beta diversity of intestinal flora of mice in different treatment groups at the OTU level was analyzed by principal coordinate analysis (PCoA). PcoA uses data dimensionality reduction to analyze the similarity of sample community composition. The closer the distance between samples, the more similar the microbial community structure. The NC group, HFD group and Lactobacillus plantarum R2-5 group can be distinguished. Lactobacillus plantarum R4-2 and R6-3 cannot be completely separated, and its distribution is between the Lactobacillus plantarum R2-5 group and the HFD group. The distance between the NC group and the HFD group is farther, and the distance between samples is significantly shortened after intervention with Lactobacillus plantarum R2-5. These results show that the HFD diet can cause intestinal flora disorders in mice, and Lactobacillus plantarum R2-5 can effectively reshape the composition of intestinal microorganisms.

[0072] like Fig.12 As shown in the figure, Chao index and Shannon index were used to analyze the α diversity of intestinal flora in mice under different treatment groups. The larger the Chao index and Shannon value, the more species are contained in the sample. The α diversity results are shown in the figure. Fig.12(A) and (B), α diversity represents the richness of sample species. According to Chao index and Shannon index, the Chao index (P<0.01) and Shannon index (P<0.01) of the HFD group were significantly lower than those of the NC group. After intervention with Lactobacillus plantarum R2-5, the abundance of Lactobacillus plantarum R2-5 increased significantly (P<0.01). The results showed that Lactobacillus plantarum R2-5 increased the richness of species.

[0073] like Fig.13 The composition and differences of intestinal flora at the phylum level in different treatment groups, such as Fig.13 As shown, the composition and differences of the intestinal flora of mice in the five different treatment groups at the phylum level can be seen. A total of 9 different phyla were identified, among which Firmicutes, Bacteroidota, Desulfobacterota, and Campilobacterota had the highest average relative abundance in the five groups. The relative abundance of Firmicutes and Bacteroidota was higher in the NC group; compared with the NC group, the abundance of Campilobacterota and Proteobacteria in the HFD group was significantly increased (P<0.05); compared with the HFD group, the abundance of Firmicutes, Deferribacterota, and Campilobacterota in Lactobacillus plantarum R2-5 was significantly increased (P<0.05), and Bacteroidota was significantly decreased (P<0.05); compared with the HFD group, the abundance of Firmicutes and Deferribacterota in Lactobacillus plantarum R4-2 and R6-3 groups was significantly increased (P<0.05).

[0074] like Fig.14 The composition and differences of intestinal flora at the genus level in different treatment groups are shown in the figure. Fig.14The composition and differences of the intestinal flora of mice in different treatment groups at the genus level can be seen. A total of 124 different genera were identified, of which the top 19 genera with an average relative abundance greater than 1% were Lachnospiraceae (Unclassified), Blautia, Colidextribacter, Oscillospiraceae (Unclassified), Lachnospiraceae (NK4A136 group), Romboutsia, Lactobacillus, Erysipelatoclostridium, Enterococcus, Bacteroides, Muribaculaceae (Unclassified), Rikenellaceae (RC9 gut group), Alistipes, Alloprevotella, Prevotellaceae (Ga6A1 group), Rikenella, Desulfovibrionaceae (Unclassified), Akkermansia, and Helicobacter.

[0075] Depend on Fig.15As can be seen, we found that Lactobacillus plantarum R2-5 treatment can promote the increase of bacteria producing SCFAs in mice induced by high-fat diet. Compared with the HFD group, Lactobacillus plantarum R2-5 treatment significantly increased the number of SCFA-producing bacteria, such as Blautia (P<0.05), Lactobacillus (P<0.01), Lachnospiraceae_UCG-006 (P<0.01), and Roseburia (P<0.01). There were also some other beneficial microorganisms, such as: the relative abundance of Turicibacter (P<0.01), Christensenella (P<0.01), and Desulfovibrionaceae (Unclassified) (P<0.01) increased significantly; compared with the HFD group, the Lactobacillus plantarum R4-2 group significantly increased Blautia (P<0.05), Lactobacillus (P<0.05) Lachnospiraceae_UCG-006 (P<0.01), Turicibacter (P<0.01) and Desulfovibrionaceae (Unclassified) (P<0.01); compared with the HFD group, the Lactobacillus plantarum R6-3 group significantly increased Desulfovibrionaceae (Unclassified) (P<0.05).

[0076] Depend on Fig.16It can be seen that compared with the NC group, some potentially harmful species or strains at the genus level related to obesity were abundant in the HFD group, including Alistipes, Bacteroides, Alloprevotella, and Bilophila. In the results of this experiment, compared with the HFD group, Lactobacillus plantarum R2-5 intervention significantly reduced the relative abundance of harmful bacteria Alistipes (P<0.05), Bacteroides (P<0.01), Alloprevotella (P<0.01), and Bilophila (P<0.01); compared with the HFD group, Lactobacillus plantarum R4-2 significantly reduced Alistipes (P<0.05), Bacteroides (P<0.05), Alloprevotella (P<0.05), and Bilophila (P<0.01); compared with the HFD group, Lactobacillus plantarum R6-3 significantly reduced Alloprevotella (P<0.01). At the genus level, Lactobacillus plantarum R2-5 had the best effect in inhibiting potential hazards associated with obesity, followed by Lactobacillus plantarum R4-2, and finally Lactobacillus plantarum R6-3. From the above results, it can be seen that Lactobacillus plantarum R2-5 can increase the intestinal short-chain fatty acid-producing bacteria and inhibit species or strains that may be potentially harmful at the genus level associated with obesity. Lactobacillus plantarum R4-2 is better than Lactobacillus plantarum R6-3, but not as good as Lactobacillus plantarum R2-5.

[0077] Correlation network analysis of the interaction between intestinal flora at the genus level. In order to better analyze the relationship between the interaction between intestinal microorganisms and their lipid metabolism in mice, the Cytoscape analysis network was used to construct the correlation network relationship between intestinal flora. This analysis used the spearman correlation analysis on the relative abundance between genus levels, and made a network diagram of the correlation coefficient r and the difference significance P, as shown in the figure below: Fig.17As shown in the figure, there are 100 nodes and 890 correlations in the network diagram. Among them, Firmicutes microorganisms account for 64%, followed by Bacteroidota accounting for 13%. The Firmicutes phylum level is mainly concentrated in the middle and around to form a complex network. It was found that Lactobacillus was positively correlated with Christensenellaceae (*Unclassified) and Clostridium sensu stricto 1. However, Christensenellaceae (*Unclassified) was positively correlated with Blautia and Lachnospiraceae (*UCG-006). Clostridium sensustricto 1 was positively correlated with Blautia. Blautia was positively correlated with Lachnospiraceae (*UCG-006). Lachnospiraceae (*UCG-006) was positively correlated with Roseburia and Oscillibacter. This transitive correlation may be due to the fact that certain small molecules, such as Lactobacillus, produce acetic acid and butyric acid in SCFAs, which can be absorbed and utilized by other flora, thereby driving the increase in the abundance of other intestinal flora and causing the intestinal flora to produce cluster sensing.

[0078] 8. Effects of short-chain fatty acids in the intestine of mice

[0079] The formation of SCFAs is the result of a complex interaction between the diet and the intestinal luminal environment of the gut microorganisms. SCFAs are a group of organic compounds produced by intestinal bacteria during the fermentation of dietary fiber. It has been shown to have many beneficial effects on human health, especially butyrate, which has received special attention for its effective anti-inflammatory, hypoglycemic and fat-reducing potential. This experiment studied the effects of Lactobacillus plantarum R2-5 on acetic acid, propionic acid, n-butyric acid, isobutyric acid, n-valeric acid, and isovaleric acid in the feces of mice fed a high-fat diet. The results are as follows Fig.18As shown. The order of SCFAs content in mouse feces is: acetate> propionate> butyrate> valeric acid> isobutyric acid> isovaleric acid, mainly composed of acetate, propionate and butyrate. Compared with the HFD group, the content of acetate, propionate, butyrate and isobutyrate increased significantly after intervention with Lactobacillus plantarum R2-5 (P<0.05), the content of butyrate increased significantly with Lactobacillus plantarum R4-2 (P<0.05), and the content of acetate, propionate and valeric acid increased significantly with R6-3 (P<0.05). The results showed that Lactobacillus plantarum R2-5 can effectively increase the content of total short-chain fatty acids in the intestine, and the increase effect of R2-5 is the most significant among the three strains, which is higher than R4-2 and R6-3. This may be due to the increase in the abundance of short-chain fatty acid-producing bacteria in the intestine after intervention with Lactobacillus plantarum R2-5. It is worth noting that the abundance of butyrate increased significantly, which may be negatively correlated with lipid accumulation.

[0080] 9. Network analysis of the correlation between short-chain fatty acid content and intestinal flora

[0081] In order to better analyze the relationship between the short-chain fatty acids produced by the mouse intestinal flora and the host lipid metabolism, the Cytoscape analysis network was used to construct a correlation network between the content of short-chain fatty acids (SCFAs) and intestinal microorganisms. Spearman correlation analysis was performed between the relative abundance of the flora and the content of short-chain fatty acids, and the correlation coefficient r and the difference significance P were made into a network diagram, as shown in the figure below: Fig.19As shown. Correlation network analysis diagram between SCFAs content in mouse feces and intestinal flora. There is a network diagram consisting of 64 nodes and 113 correlations in the figure (r>|0.5|, P<0.05). Butyric acid is connected to 43 nodes, acetic acid is connected to 6 nodes, propionic acid is connected to 12 nodes, isobutyric acid is connected to 9 nodes, isovaleric acid is connected to 25 nodes, and valeric acid is connected to 18 nodes. It can be seen from the figure that butyric acid is the central node of the network, among which 24 bacteria belong to the Firmicutes phylum and 7 bacteria belong to the Bacteroidota level. These two phyla account for more than 70% of the bacteria connected to butyric acid. The 7 bacterial genera under the Bacteroidota phylum connected to butyric acid are negatively correlated. In addition, among the bacteria related to butyric acid, Blautia (r=0.5, P<0.05), Lachnospiraceae (*UCG-006) (r=0.6, P<0.01), Desulfovibrionaceae (*Unclassified) (r=0.4, P<0.05), Eubacterium brachy group (r=0.5, P<0.05), Roseburia (r=0.4, P<0.05), and Turicibacter (r=0.5, P<0.01) were positively correlated with butyric acid, and Bilophila (r=-0.5, P<0.01) was negatively correlated.

[0082] In the environment of high-fat diet feeding, after 12 weeks of intervention with Lactobacillus plantarum R2-5, the amount of acetic acid and lactic acid increased, which led to an increase in the abundance of Blautia, Lachnospiraceae_UCG-006, Eubacterium brachy group, Roseburia, and Turicibacter bacteria. Among them, Blautia, Turicibacter, and Roseburia can also produce butyrate. Butyrate, a small molecule, can enter cells and cause cluster induction between intestinal flora. It can be seen from the network diagram that butyrate drives changes in 43 strains of intestinal microorganisms, which leads to changes in the structure of intestinal flora, thereby changing the metabolic function of the host.

[0083] 10. Correlation analysis between short-chain fatty acid content and intestinal flora function prediction

[0084] Based on the results of the above experiments on mice, it can be seen from the analysis that in terms of inhibiting the increase in blood lipids and lipid synthesis induced by a high-fat diet in mice, Lactobacillus plantarum R2-5 and R4-2 are significantly better than R6-3 in various indicators. Therefore, in the following lipid-lowering metabolic pathway prediction analysis, Lactobacillus plantarum R2-5 and R4-2 are focused on. Based on the KEGG database, PICRUSt was used to predict the function of the 16S rRNA sequencing data of the mouse intestinal flora. In order to clearly study the lipid-lowering mechanism of SCFAs, the ko pathway was correlated with the SCFAs content. The results are as follows Fig. 20 As shown. Taking into account the structural changes, the 16S rRNA data were further analyzed and the metabolic profile of the intestinal flora was predicted by PICRUSt analysis. 299 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were predicted. After HFD diet induction, 79 pathways were significantly different between the NC group and the HFD group (P<0.05), however, 142 pathways were significantly different after intervention with Lactobacillus plantarum R2-5 compared with the HFD group (P<0.05). There were 58 pathways that were significantly different between the NC group and the HFD group, and between the HFD group and the R2-5 group. Among these 58 pathways, there are 2 in Carbohydrate metabolism, 2 in Lipid metabolism, 6 in Aminoacid metabolism, 1 in Translation, 2 in Global and overviewmaps, 2 in Drug resistance antimicrobial, 1 in Transport and catabolism, 2 in Aging, 1 in Cell growth and death, 4 in Endocrine system, 1 in Endocrine and metabolic disease, 2 in Cancer specific types, 1 in Immune system, etc.

[0085] The most interesting thing in this study is that after HFD diet induction, nine KEGG pathways, including fatty acid metabolism, glycerolipid metabolism, steroid metabolism, and starch and sucrose metabolism, were significantly enriched after intervention with Lactobacillus plantarum R2-5. In order to more clearly study the relationship between metabolic pathways and SCFAs, spearman correlation analysis was used. In the network diagram, we can see that butyrate is associated with 100 metabolic pathways, of which 29 are positively correlated and 71 are negatively correlated. It is worth noting that among these 71 negative correlations, 4 are lipid metabolism. They are ko00062, fatty acid elongation, ko00100, steroid biosynthesis, ko00140, steroid hormone biosynthesis, and ko01040, biosynthesis of unsaturated fatty acids. The increase in butyrate weakens the above lipid metabolic pathways. It is speculated that after the intervention of Lactobacillus, cluster induction occurred between intestinal flora, causing changes in the composition of intestinal flora. Butyrate reduced the abundance of bacteria with these functions, and regulated the metabolism of intestinal flora through butyrate, thereby inhibiting lipid metabolism. Statistical analysis of the above four pathways showed that the R2-5 group was significantly downregulated compared with the HFD group (P<0.05).

[0086] Butyrate was positively correlated with 29 metabolic pathways, of which 5 were carbohydrate metabolism. It is worth noting that there are 5 carbohydrate metabolisms as follows: ko00030, i.e., pentose phosphate pathway, ko00040, i.e., pentose and glucuronate interconversions, ko00051, i.e., fructose and mannose metabolism, ko00500, i.e., starch and sucrose metabolism, and ko00640, i.e., propionate metabolism. It can be seen from these 5 pathways that the increase of butyrate upregulates the upstream pathways of butyrate production.

[0087] 11. Explore metabolic pathways and key metabolites based on multi-omics technology

[0088] PICRUSt analysis of the functional profile of microbial communities based on 16S rRNA genes, such as Fig.21As shown. First, compared with the HFD group, the R2-5 group showed significant changes in KEGG pathways related to lipid metabolism, including lysine biosynthesis (P<0.05), methionine biosynthesis (P<0.05), carnitine synthesis (P<0.05), and fatty acid biosynthesis (P<0.05). Carnitine is synthesized from lysine and methionine. In the PICRUSt analysis, the KEGG orthologs in the R2-5 group were significantly enhanced compared with the HFD group ( Fig.21 B), for example, the KEGG orthologous genes in the lysine biosynthesis pathway included K00215 (P<0.05), K00821 (P<0.05), K01439 (P<0.05), K01778 (P<0.05), and K01587 (P<0.05). Similarly, K01760 (P<0.05) and K00548 (P<0.05) in the methionine biosynthesis pathway were significantly enhanced in the R2-5 group compared with the HFD group (P<0.05). Fig.21 (B). Enhancing the biosynthesis of lysine and methionine can provide sufficient raw materials for carnitine synthesis. Fig.21 (H) Metabolomics results showed that compared with the HFD group, the R2-5 group had a significant increase in the precursor of carnitine synthesis, "N6,N6-dimethyl-L-lysine" in the intestine (P<0.05). The increase in carnitine synthesis substrates enables more carnitine to be synthesized in the liver, thereby promoting the β-oxidation of long-chain fatty acids and ultimately achieving a reduction in body weight and lipids.

[0089] Second, compared with the HFD group ( Fig.21 CF), the R2-5 group significantly downregulated KOs in the fatty acid biosynthesis pathway, including K00632 (P<0.05), K01825 (P<0.05), K01782 (P<0.05), and K06445 (P<0.05). This resulted in the inhibition of long-chain fatty acid synthesis. In addition, we found that K01034 was significantly enhanced in the R2-5 group compared with the HFD group (P<0.05). Fig.21 G), which may be related to the inhibition of long-chain fatty acid synthesis and the increase of butyrate.

[0090] at last, Fig.21 I showed that glycerol degradation was increased. Compared with the HFD group, K00128(P<0.05), K0002(P<0.05), K00005(P<0.05), K00863(P<0.05), K06120(P<0.05), K00086(P<0.05), K00864(P<0.05), K08591(P<0.05), K00655(P<0.05), and K03621(P<0.05) in the R2-5 group were significantly upregulated. Fig.21IJ), promoting the degradation of glycerol to produce propane-1,3-diol, D-glyceric acid, phosphoglycerone, and phosphatidic acid, thereby reducing the raw materials for triglyceride synthesis, that is, glycerol is decomposed.

[0091] 12. Mechanism of lipid-lowering effect of Lactobacillus plantarum R2-5

[0092] like Fig. 22As shown, the composition of the intestinal flora of mice changed after intervention with Lactobacillus plantarum R2-5. First, it is worth noting that butyrate diverts the biosynthesis pathway of long-chain fatty acids and reduces the synthesis of long-chain fatty acids (ko01212). The reduced synthesis of long-chain fatty acids in the intestinal microbiota reduces the amount of free fatty acids absorbed by the body. Secondly, glycerol metabolism (ko00561) is mainly involved in catabolism, thereby inhibiting lipid synthesis. Finally, carnitine plays a vital role in energy metabolism, and carnitine acts as a carrier for β-oxidation of long-chain fatty acids in mitochondria. In addition, carnitine is synthesized from lysine and methionine. PICRUSt analysis showed that the lysine biosynthesis pathway (ko00300) and the methionine biosynthesis pathway (ko00270) were significantly upregulated. This suggests that an increase in the raw materials available for carnitine synthesis will lead to an increase in carnitine levels. Importantly, metabolome testing of mouse feces was performed to further verify the PICRUSt prediction analysis, and the results showed that the precursor of carnitine synthesis, N6,N6-dimethyl-L-lysine, was significantly increased in the R2-5 group. According to research by Charles L et al., rats injected with N6,N6,N6-Trimethyl-L-lysine using isotope labeling can synthesize carnitine through the liver. However, in this study, the R2-5 group had a very significant increase in N6,N6-dimethyl-L-lysine. Methylation is required to convert N6,N6-dimethyl-L-lysine to N6,N6,N6-Trimethyl-L-lysine, and this reaction is completed autonomously using the enzyme [histoneH3]-lysine4 N-trimethyltransferase MLL1 encoded by the gene Kmt2a in mice. This enzyme is responsible for trimethylating the lysine residue at position 4 (K4) of lysine on histone H3 to form H3K4me3 (https: / / www.kegg.jp / entry / mmu:214162). Therefore, R2-5 can promote the production of carnitine precursor N6, N6-dimethyl-L-lysine, increase the substrate for carnitine synthesis, and convert more carnitine into carnitine in the liver. Long-chain fatty acids are activated into acyl-CoA in the cytoplasm, and acyl-CoA needs carnitine as a carrier to enter the mitochondrial membrane for β-oxidation. Therefore, the increase in carnitine content will promote the β-oxidation of long-chain fatty acids, thereby achieving weight loss and lipid reduction.

Claims

1. A Sayram yogurt source plant lactobacillus (Lactiplantibacillus plantarum) R2-5, characterized in that: Its deposit number is CGMCC NO.31107.

2. Application of Lactiplantibacillus plantarum R2-5 derived from Sayram yogurt in the preparation of a composition capable of preventing lipid accumulation by regulating intestinal flora.

3. A composition, characterized in that It comprises the Sayram yogurt-derived Lactobacillus plantarum R2-5 as described in claim 1.

4. A food, characterized in that It comprises the Sayram yogurt-derived Lactobacillus plantarum R2-5 as described in claim 1.

5. A food additive, characterized in that: It comprises the Sayram yogurt-derived Lactobacillus plantarum R2-5 as described in claim 1.

6. A microbial preparation, characterized in that: It comprises the Sayram yogurt-derived Lactobacillus plantarum R2-5 as described in claim 1.

7. A pharmaceutical composition, characterized in that It comprises the Sayram yogurt-derived Lactobacillus plantarum R2-5 as described in claim 1.

Citation Information

Patent Citations

  • Lactobacillus plantarum with abilities of reducing cholesterol and promoting intestinal short chain fatty acid generation ability and application of lactobacillus plantarum

    CN108728382A

  • Lactobacillus plantarum strain LP4 and application thereof

    CN110591942A

  • Lactobacillus plantarum for efficiently lowering in-vivo cholesterol level and application of lactobacillus plantarum

    CN110616173A

  • Application of lactobacillus plantarum powder in regulating fat metabolism and intestinal flora of obese rats

    CN111467506A

  • Lactobacillus plantarum ZJUFYJ7 and application thereof

    CN114317353A